SEHNALOVÁ, Irena, Barbora ŘÍHOVÁ and Regina DEMLOVÁ. The Real-World Cost Study of Treating mCRC with Bevacizumab Followed by EGFRi in WT KRAS patients. In 69. Česko-slovenské farmakologické dny. 2019.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Real-World Cost Study of Treating mCRC with Bevacizumab Followed by EGFRi in WT KRAS patients
Authors SEHNALOVÁ, Irena, Barbora ŘÍHOVÁ and Regina DEMLOVÁ.
Edition 69. Česko-slovenské farmakologické dny, 2019.
Other information
Original language English
Type of outcome Conference abstract
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Organization unit Faculty of Medicine
Keywords (in Czech) bevacizumab - cetuximab – panitumumab – kolorektální karcinom – analýza nákladů
Keywords in English bevacizumab - cetuximab – panitumumab – colorectal carcinoma – cost analysis
Tags International impact, Reviewed
Changed by Changed by: Mgr. Barbora Říhová, Ph.D., učo 52482. Changed: 12/2/2020 09:31.
PrintDisplayed: 26/7/2024 22:11